OClawVPS.com
Genedant
Edit

Genedant

https://genedant.com
Last activity: 25.03.2026
Active
Invests in categories: MaterialsFoodTechProductHealthTechResearchSkinScienceITDevelopmentAlternative
Genedant Capital is an investment firm offering comprehensive and bespoke financial services towards asset management, wealth preservation and portfolio growth. We strive to become one of Asia’s premium independent asset managers by delivering consistent risk-adjusted returns for our clients through active investments in portfolio and opportunities. One of Genedant's investment focuses is in venture capital. Genedant Ventures invests in emerging science and technology ventures and challenges conventional thinking of what is possible. We back like-minded academics, clinicians and technologists and focus on life science technologies with wide ranging applications such as biomedical and agrifood sectors.
Followers
626
Portfolio
11
Mentions
5
Location: Singapore
Employees: 1-10
Founded date: 2020
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A

Portfolio 11

DateNameWebsiteTotal RaisedLocation
25.03.2026RyboDynrybodyn.com$14MUnited Sta...
-Sanomicssanomics.com-United Sta...
-xinterrate...xinterra.tech--
-JUST Eggju.st$677.51MUnited Sta...
-Meatiplymeatiply.com$3.75M-
-Auristone ...auristone.com-Singapore
-Umami Meat...umamimeats.com$2.4M-
-Qurioqurio.com.sg-Singapore
-Ripple Foo...ripplefoods.com$209MUnited Sta...
-Peptobioti...peptobiotics.com$6.2MSingapore,...
Show more

Mentions in press and media 5

DateTitleDescription
27.03.2026RyboDyn Secures $10M Seed Funding for AI-Powered Cancer Target DiscoveryBiotech firm RyboDyn landed $10 million in seed funding. The San Diego company pioneers an AI-driven platform. It decodes the "dark proteome." This unlocks hidden cancer targets. Traditional methods miss these crucial markers. The...
25.03.2026RyboDyn: $10 Million Seed Funding Raised For AI-Powered Cancer Target DiscoveryRyboDyn, a biotechnology company focused on decoding the dark proteome to uncover new cancer targets, announced the initial close of a $10 million seed financing round. The company said the funding will support its transition from foundatio...
29.06.2022Sequential awarded prestigious Innovate UK SMART Grant to propel understanding of skin microbiome forwardLONDON and NEW YORK and SINGAPORE, June 29, 2022 /PRNewswire/ -- Sequential Skin Ltd, a leading skin genomics start-up, has been awarded an Innovate UK SMART Grant to fund a project on advancing current understanding of the skin microbiome ...
11.10.2021Sequential Skin : raise US $1.65M in oversubscribed seed round to revolutionise skin health with their novel skin microbiome testing kitLONDON, Oct. 11, 2021 /PRNewswire/ -- Sequential Skin Ltd, a UK/Singapore biotech start-up has raised US $1.65M in its oversubscribed seed round – to revolutionise the future of skin health. The round was led by Metaplanet, and supported by...
11.10.2021Sequential Skin raise US $1.65M in oversubscribed seed round to revolutionise skin health with their novel skin microbiome testing kitLONDON, Oct. 11, 2021 /PRNewswire/ -- Sequential Skin Ltd, a UK/Singapore biotech start-up has raised US $1.65M in its oversubscribed seed round – to revolutionise the future of skin health. Sequential Skin team: Dr Oliver Worsley, CEO/cofo...

Reviews 0

Sign up to leave a review

Sign up Log In